NPPA notified regarding the computation of the retail price of Atorvastatin Calcium IP eq. to Atorvastatin 10 mg + Ezetimibe IP 10 mg for M/s Pure & Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer)

Jan 13, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific Complianceclass="MsoNormal">The National Pharmaceutical Pricing Authority (NPPA) on January 12, 2025, notified regarding the computation of the retail price of Atorvastatin Calcium IP eq. to Atorvastatin 10 mg + Ezetimibe IP 10 mg for M/s Pure & Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer).

It states that the price of each film-coated tablet containing:- Atorvastatin Calcium IP eq. to Atorvastatin 10 mg + Ezetimibe IP 10 mg for M/s Pure & Cure Healthcare Pvt. Ltd. (Manufacturer) & M/s Mankind Pharma Ltd. (Marketer) has been revised to Rs. 20.00/-.

 

[Notification no: 19(4980)/2025/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT